Our latest publication in @ScienceAdvances is officially out!
Here, we target the NPY/NPY1R signalling axis to lessen metastatic burden of mutant p53-dependent #PancreaticCancer 🔬👩🏼🔬
Check it out here:
https://t.co/plZXXue5Lf
@GarvanInstitute@Timpson_Lab
Happy to share our latest review on the varied mechanisms of immune escape throughout metastatic progression- a fantastic effort by Nicole Haynes @Nicole160368 supported by @thomasbchadwick
@alshamsi2000 لا إله إلا الله، اللهم إن رحمتك وسعت كل شيء، فارحمها رحمة تطمئن بها نفسها، وتقر بها عينها، اللهم احشرها مع المتقين إلى الرحمن وفدا، اللهم احشرها مع أصحاب اليمين، واجعل تحيتها سلام لك من أصحاب اليمين.
Started my research career in Australia with James, he was RA and I was an intern, I look forward to see all the great things you will achieve mate!! Still better than you in Call of Duty though!
I am super proud to see James establish his own lab after a truly amazing 6 years in @IvaskaLab. If you want to see great things in the future, whatch this space ✨️ https://t.co/mnrAWjTgNt
In our new publication in @CellReports,
we established a series of compound mutant mice harbouring KRAS, PI3K and TP53 mutations and corresponding organoids to investigate the dependency on IL6/IL11/STAT3 signalling for each gastric cancer disease step. https://t.co/vzMOM2Nhrn
Thrilled to share our recent work in @CellReports , led by Dr Moritz Eissmann (@EissmannMo95094 ) Dr Anne Huber, Prof Matthias Ernst (@lab_ernst) and myself.
@DonalWallLab @UofG_micro@UofGSii@UofGMVLS Congratulations Donal!! Got my first paper in your lab! Sorry for destroying the centrifuge on my first day! 🫡
A Post Doc position is available in my Molecular Immunology lab (MIL) @ONJCRI. Co-appointment with @Vervoort_Lab@WEHI_research. If you are interested in new tech (CRISPR and singe cell) to study Cancer Immunology please get in touch!